You do not currently have access to this content.
Cancer Res (2022) 82 (12_Supplement): 3597.
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Cancer Res (2025) 85 (8_Supplement_2): ND11.
Cancers arising from oral cavity and oropharynx are commonly treated with radiotherapy, whereas tumor radioresistance results in poor outcome. The prerequisite for developing more effective ...
Mol Cancer Ther (2025) 24 (10_Supplement): B116.
In solid tumors, the number of T cells is limited, and immunosuppressive cells in the tumor microenvironment, such as cancer-associated fibroblasts (CAFs), myeloid-derived suppressor cells (MDSCs), ...
1Center for Advanced Innate Cell Therapy, Texas Children’s Hospital, Houston, Texas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results